Drug intelligence / Profile preview

异常黑胆质清除剂

Development stage: Unknown
Lead developer: Xinjiang Uygur Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

异常黑胆质清除剂是一种源自维吾尔医学理论的中药复方制剂，主要用于“清除异常黑胆质及胆液质，除障明目”，临床上主要用于白内障等眼科疾病。其配方通常包含多味中草药，通过调节体液、气质以达到防治相关疾病的目的。现代研究显示，该类制剂具有抗氧化、消除自由基、保护DNA免受氧化损伤等作用机制，有助于改善机体抗氧化能力，并可能通过调节能量代谢和氨基酸代谢对肿瘤及其他慢性病变产生积极影响[3][5][9]。

Targets

DNA

Beyond the preview

Go deeper on 异常黑胆质清除剂.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 异常黑胆质清除剂.

Explore the full profile